Primary Care Preconference
Saturday, July 13, 2013
Alzheimer's Disease in Primary Care Settings
|
|
| Overview | Learning objectives |
| Target audience | Accreditation statement |
| Program Co-Chairs | Credit designation |
| Program | Disclosure of conflicts of interest |
|
|
Overview
Designed for practicing physicians, this preconference will include information and sessions on the following areas:
- Research, including new diagnostic criteria, diagnostic process, disease-modifying drugs and what lies ahead.
- Early identification of Alzheimer's disease, including screening.
- Medical treatment of Alzheimer's disease, including disease-related treatments and behavioral treatments.
- Ongoing care management, including the role of the general practitioner, care planning, care environments, caregiver support and community resources.
- Research opportunities for general practitioners.
Target audience
All clinicians involved in the care of or research on individuals with memory or other cognitive complaints, including but not limited to neurologists, psychiatrists, radiologists, geriatricians, and neuropsychologists; as well as researchers, industry and regulatory agencies stakeholders, and others involved in the use of imaging techniques in the study of Alzheimer's disease, related disorders and normal aging.
Program Co-Chairs
Alireza Atri, M.D., Ph.D.
Assistant in Neurology, Memory Disorders Unit, Massachusetts General Hospital
Associate Director, Clinical Programs, Geriatric Research, Education and Clinical Center, ENRM VA,
Bedford Medical Center
Instructor in Neurology, Harvard Medical School
Bradford C. Dickerson, M.D., M.MSci.
Director, Frontotemporal Dementia Unit and Director, Laboratory of Neuroimaging,
Co-Director, Neuroimaging Group, Gerontology Research Unit and
MA Alzheimer’s Disease Research Center, Massachusetts General Hospital
Associate Professor of Neurology, Harvard Medical School
Eric G. Tangalos, M.D., F.A.C.P., A.G.S.F., C.M.D.
Professor of Medicine and Co-Director for Education
Mayo Clinic Alzheimer’s Disease Research Center
Program
8:30-8:40 a.m. |
Welcome and Overview |
8:40-9:05 a.m. |
Clinical Diagnosis and Care of Dementia – Why It Matters |
9:05-9:35 a.m. |
Alzheimer’s Disease: State of the State |
9:35-10:15 a.m. |
The New Criteria for Detection and Diagnosis of AD: From Symptoms and Signs to Neuropsychology, Neuroimaging and CSF |
10:15-10:45 a.m. |
Diagnosis of “The Other Dementias”: Not Uncommon or Necessarily Isolated Dr. Bradford Dickerson |
10:45-11 a.m. |
Break |
11-11:30 a.m. |
Where the Rubber Meets the Road: Application and Implications of the New AD Criteria for Primary Care Practice |
11:30 a.m.-12 p.m. |
Panel Q&A |
12-1 p.m. |
Lunch |
1-1:30 p.m. |
Sowing the Seeds of Hope: The Potential to Slow Disease Now and Prevent Dementia in the Future |
1:30-2:10 p.m. |
Pharmacological Treatment of Alzheimer’s Disease: Evidence, Expectations and Ambiguities |
2:10-2:45 p.m. |
The Importance of Family/Caregivers in the Care of People with Alzheimer’s |
2:45-3 p.m. |
Break |
3-3:20 p.m. |
Driving and Dementia |
3:20-3:50 p.m. |
The Front Lines: A Non-Pharmacological Approach to Neuropsychiatric Symptoms and Problem Behaviors in Dementia |
3:50-4:20 p.m. |
Backed-Up Against the Wall: Pharmacology to Assuage the PAADS (Psychosis, Apathy, Agitation, Depression, Sleep Problems) Clusters in Dementia |
4:20-4:50 p.m. |
Panel Q&A |
4:50-5 p.m. |
Closing remarks |
Learning objectives
At the end of this educational activity, attendees should be able to:
- Recognize the importance and ethical considerations of early diagnosis.
- Explain the cognitive, functional and behavioral treatment of Alzheimer's disease.
- Identify the fundamentals of care management for persons with Alzheimer's.
- Recognize Alzheimer's research opportunities for general practitioners.
Accreditation statement
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Postgraduate Institute for Medicine and the Alzheimer's Association. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit designation
The Postgraduate Institute for Medicine designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of conflicts of interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.
Spotlight
Registration and housing are now open! Join us to celebrate 25 years of discovery, progress and change at AAIC in Boston, United States, July 13-18, 2013.
Register now.
2013 Primary Care Sponsors |
|
